59 reports

Top ## players hold majority of stake in the market ##.

  • Depression
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.

You can easily book an appointment with one online.

  • Depression
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

One of the driving factors is the increasing healthcare expenditure, which is influenced by the rise in disposable income.

  • Depression
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

Global Vaccines, Oncology, and Consumer Healthcare (VOC): Global Vaccines, oncology, and Consumer healthcare (VOC) focuses on development and commercialization of vaccine and products.

  • Depression
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.

LONG-TERM MENTAL HEALTH CARE FOR PEOPLE WITH SEVERE MENTAL DISORDERS.

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.

IS THE GLOBAL HEAD AND EVP OF HEALTHCARE OPERATIONS AND STRATEGY.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

It is the largest telephone-based healthcare survey in the world.

  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc

Healthcare Expenditure (2009-2015) Global Female Population (2010-2015) Global Depressive Disorder Market Revenue Comparison (2015) Global Anti-Depressant Market Share by Drugs (2015) Global Anti-Depressant Drug Revenue Comparison (2018) Global Anti-Psychotic Market Share by Drugs (2015) Gl

  • Antipsychotic
  • Depression
  • Therapy
  • World
  • Forecast

Major Depressive Disorder - Current and Future Players ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Market Outlook ## ##. ## Global Markets ## ##. ##. ## Forecast ## ##. ##. ## Drivers a

  • Depression
  • Therapy
  • World
  • Company
  • Demand

Psychiatry; ##(##): ##-##.

  • Depression
  • Japan
  • United States
  • World
  • Forecast

Major Depressive Disorder - ##EU Drug Forecast and Market Assessment to 2025 ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Disease Overview ## ##. ## Etiology and Pathophy

  • Depression
  • Mental Health
  • Therapy

Major Depressive Disorder - US Drug Forecast and Market Assessment to 2025 ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Disease Overview ## ##. ## Etiology and Pathophys

  • Depression
  • Therapy
  • United States

Major Depressive Disorder - Japan Drug Forecast and Market Assessment to 2025 ## Table of Contents ## Table of Contents ## ##. ## List of Tables ## ##. ## List of Figures ## ## Introduction ## ##. ## Related Reports ## ##. ## Upcoming Related Reports ## ## Disease Overview ## ##. ## Etiology and Pathop

  • Depression
  • Therapy
  • Japan
  • Demand

One St.

  • Depression
  • United States
  • GlobalData's company
  • Jude Medical, Inc.
  • Thoratec Corporation

It is the largest telephone-based healthcare survey in the world.

  • Depression
  • United States
  • Actavis plc
  • Eli Lilly & Co.
  • GlaxoSmithKline plc

Sage Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 Sage Therapeutics Inc' s, deal volume decreased from three pharmaceuticals & healthcare deals in 2015 to two pharmaceuticals & healthcare deals in 2016.

  • Depression
  • United States
  • World
  • Company Financials
  • SAGE Therapeutics

The company' s deal volume decreased from two pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Depression
  • Pharmaceutical
  • United States
  • Company
  • RespireRx Pharmaceuticals Inc.

Each share of common stock is sold together with a warrant to purchase one share of common stock.

  • Depression
  • Therapy
  • United States
  • Company
  • VistaGen Therapeutics, Inc.

The company' s deal volume increased from one pharmaceuticals & healthcare deal in 2016 to six pharmaceuticals & healthcare deals in 2017.

  • Depression
  • Pharmaceutical
  • Therapy
  • United States
  • Lundbeck Inc.

The company' s deal volume decreased from two pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Depression
  • United States
  • Company
  • Company Operations
  • SAGE Therapeutics

GlobalData Neuralstem Inc' s, deal volume decreased from three pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Depression
  • United States
  • Company
  • Company Operations
  • Neuralstem, Inc.

GlobalData offers comprehensive geographic coverage across world' s most important sectors, focusing particularly on energy and healthcare.

  • Depression
  • Stroke
  • United States
  • Company Financials
  • Nexstim Plc

Increasing prevalence of mental disorders, rapidly changing healthcare sector, and increasing healthcare spending are driving the growth for Asia Pacific depression screening market.

  • Depression
  • North America
  • United States
  • World
  • Demand

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Depression
  • Therapy
  • World
  • Product Initiative
  • Suven Life Sciences Ltd

MAR ##, 2015: SUVEN LIFE SECURES ONE (##) PRODUCT PATENT EACH IN EURASIA AND ISRAEL The U. S.

  • Depression
  • Psychotic Disorder
  • United States
  • World
  • Product Initiative

Medison provides integrated services for international healthcare companies to expand their presence in Israel and Romanian healthcare markets.

  • Depression
  • Israel
  • United States
  • Company
  • Brainsway Ltd.

IT CAN BE DIFFICULT TO STRIKE THE RIGHT BALANCE OF STIMULATION BECAUSE IF IT S TOO HIGH THE PATIENT WILL BE HYPOMANIC AND IF IT S TOO LOW IT WON T WORK, GOODMAN SAID.

  • Clinical Trial
  • Depression
  • Mental Health
  • Therapy
  • GlobalData's company

Note: Deals include all announced pharmaceuticals & healthcare deals from 2011 onwards, GlobalData University of California Davis, Medical Devices Deals, 2011 to YTD 2017 Device Type Anesthesia and Respiratory Devices HealthCare IT In Vitro Diagnostics No. of Deals

  • Depression
  • Healthcare
  • United States
  • Deals & Alliance
  • GlobalData's company

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Depression
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Suven Life Sciences Ltd

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Depression
  • Psychotic Disorder
  • United States
  • Product Initiative
  • Suven Life Sciences Ltd